Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study

Abstract Objective: Hazardous drugs presence at Hospital Pharmacies has been demonstrated in numerous studies. This study aims to analyze the presence and levels of hazardous drugs at Spanish Hospital Pharmacies and the influence of different aspects on them. Method: We developed a cross test at Hospital Pharmacies hazardous drugs compounding surfaces of ten Spanish hospitals. An independent laboratory determined cyclophosphamide, iphosphamide and 5-fluorouracile levels in samples recovered. Annual number of hazardous drugs compounded, as well as the number of preparations developed the testing day was registered. We also registered cleaning and decontamination processes and the drug transfer device used at each hospital. Results: 204 samples were analyzed. Hazardous drugs presence was confirmed in all participant hospitals. We observed a 49%, 23% and 10% of positive samples for cyclophosphamide, iphosphamide and 5-fluorouracile. Median levels (first-third quartile) of cyclophosphamide, iphosphamide and 5-fluorouracile were 0.05 ng/cm2 (0.03-0.23), 0.03 ng/cm2 (0.03-0.06) y 0.31 ng/cm2 (0.3-0.59) respectively. Conclusions: Present study confirms hazardous drugs presence on compounding areas at Spanish Hospital Pharmacies departments. We observed a significant variability between participant hospitals, as well as between tested locations. Samples with more positive results were cabine airfoils and floors in front of them. The number of preparations had no influence on results observed. Variability observed points outs the need to standardized compounding hazardous drugs processes.

Saved in:
Bibliographic Details
Main Authors: Valero-García,Silvia, Poveda-Andrés,José Luis
Format: Digital revista
Language:English
Published: Grupo Aula Médica 2018
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432018000400152
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1130-63432018000400152
record_format ojs
spelling oai:scielo:S1130-634320180004001522020-11-05Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric studyValero-García,SilviaPoveda-Andrés,José Luis Hazardous substances Environmental contamination Drug compounding Occupational exposure Antineoplastic drugs Surface contamination Abstract Objective: Hazardous drugs presence at Hospital Pharmacies has been demonstrated in numerous studies. This study aims to analyze the presence and levels of hazardous drugs at Spanish Hospital Pharmacies and the influence of different aspects on them. Method: We developed a cross test at Hospital Pharmacies hazardous drugs compounding surfaces of ten Spanish hospitals. An independent laboratory determined cyclophosphamide, iphosphamide and 5-fluorouracile levels in samples recovered. Annual number of hazardous drugs compounded, as well as the number of preparations developed the testing day was registered. We also registered cleaning and decontamination processes and the drug transfer device used at each hospital. Results: 204 samples were analyzed. Hazardous drugs presence was confirmed in all participant hospitals. We observed a 49%, 23% and 10% of positive samples for cyclophosphamide, iphosphamide and 5-fluorouracile. Median levels (first-third quartile) of cyclophosphamide, iphosphamide and 5-fluorouracile were 0.05 ng/cm2 (0.03-0.23), 0.03 ng/cm2 (0.03-0.06) y 0.31 ng/cm2 (0.3-0.59) respectively. Conclusions: Present study confirms hazardous drugs presence on compounding areas at Spanish Hospital Pharmacies departments. We observed a significant variability between participant hospitals, as well as between tested locations. Samples with more positive results were cabine airfoils and floors in front of them. The number of preparations had no influence on results observed. Variability observed points outs the need to standardized compounding hazardous drugs processes.Grupo Aula MédicaFarmacia Hospitalaria v.42 n.4 20182018-08-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432018000400152en
institution SCIELO
collection OJS
country España
countrycode ES
component Revista
access En linea
databasecode rev-scielo-es
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Valero-García,Silvia
Poveda-Andrés,José Luis
spellingShingle Valero-García,Silvia
Poveda-Andrés,José Luis
Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
author_facet Valero-García,Silvia
Poveda-Andrés,José Luis
author_sort Valero-García,Silvia
title Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
title_short Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
title_full Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
title_fullStr Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
title_full_unstemmed Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
title_sort hazardous drugs levels in compounding area surfaces of hospital pharmacies services: multicentric study
description Abstract Objective: Hazardous drugs presence at Hospital Pharmacies has been demonstrated in numerous studies. This study aims to analyze the presence and levels of hazardous drugs at Spanish Hospital Pharmacies and the influence of different aspects on them. Method: We developed a cross test at Hospital Pharmacies hazardous drugs compounding surfaces of ten Spanish hospitals. An independent laboratory determined cyclophosphamide, iphosphamide and 5-fluorouracile levels in samples recovered. Annual number of hazardous drugs compounded, as well as the number of preparations developed the testing day was registered. We also registered cleaning and decontamination processes and the drug transfer device used at each hospital. Results: 204 samples were analyzed. Hazardous drugs presence was confirmed in all participant hospitals. We observed a 49%, 23% and 10% of positive samples for cyclophosphamide, iphosphamide and 5-fluorouracile. Median levels (first-third quartile) of cyclophosphamide, iphosphamide and 5-fluorouracile were 0.05 ng/cm2 (0.03-0.23), 0.03 ng/cm2 (0.03-0.06) y 0.31 ng/cm2 (0.3-0.59) respectively. Conclusions: Present study confirms hazardous drugs presence on compounding areas at Spanish Hospital Pharmacies departments. We observed a significant variability between participant hospitals, as well as between tested locations. Samples with more positive results were cabine airfoils and floors in front of them. The number of preparations had no influence on results observed. Variability observed points outs the need to standardized compounding hazardous drugs processes.
publisher Grupo Aula Médica
publishDate 2018
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432018000400152
work_keys_str_mv AT valerogarciasilvia hazardousdrugslevelsincompoundingareasurfacesofhospitalpharmaciesservicesmulticentricstudy
AT povedaandresjoseluis hazardousdrugslevelsincompoundingareasurfacesofhospitalpharmaciesservicesmulticentricstudy
_version_ 1755939095938334720